ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial A Randomized, Double-Blind Study Evaluating the Efficacy, Safety and Immunogenicity of ABP 798 Compared with Rituximab in Subjects with CD20 Positive B-Cell Non-Hodgkin Lymphoma (NHL)
EudraCT number 2013-005542-11
Protocol number 20130109
Sponsor Amgen Inc.,One Amgen Center Drive,Thousand Oaks,CA 91320
Indications Hemato-oncology
Diagnosis Non-Hodgkin lymphoma
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2014
Date of approval by Institute (SÚKL) 30.7.2014
Date of approval by EC 22.5.2014
Date of initiation CT in ČR 13.5.2016
Date of ending CT in ČR 28.6.2019 (10.7.2019
Sites Oblastní nemocnice Mladá Boleslav, a.s.,Hematologicko-transfuzní oddělení,V. Klementa 147 ,Mladá Boleslav,293 50
Fakultní nemocnice Královské Vinohrady,Interní hematologická klinika,Šrobárova 1150/50 ,Praha 10,100 34
Fakultní nemocnice v Motole,Onkologická klinika ,V Úvalu 84,Praha 5,150 06
Fakultní nemocnice Ostrava,Klinika hematoonkologie ,17. listopadu 1790,Ostrava,708 52

‹‹ Back to list